These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9079708)

  • 1. Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling.
    Ueno H; Sasaki K; Miyagawa K; Honda H; Mitani K; Yazaki Y; Hirai H
    J Biol Chem; 1997 Mar; 272(13):8739-43. PubMed ID: 9079708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
    Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
    Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.
    Galisteo ML; Dikic I; Batzer AG; Langdon WY; Schlessinger J
    J Biol Chem; 1995 Sep; 270(35):20242-5. PubMed ID: 7657591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation.
    Wang L; Rudert WA; Loutaev I; Roginskaya V; Corey SJ
    Oncogene; 2002 Aug; 21(34):5346-55. PubMed ID: 12149655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.
    Levkowitz G; Waterman H; Ettenberg SA; Katz M; Tsygankov AY; Alroy I; Lavi S; Iwai K; Reiss Y; Ciechanover A; Lipkowitz S; Yarden Y
    Mol Cell; 1999 Dec; 4(6):1029-40. PubMed ID: 10635327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl.
    Yoon CH; Lee J; Jongeward GD; Sternberg PW
    Science; 1995 Aug; 269(5227):1102-5. PubMed ID: 7652556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development.
    Meisner H; Daga A; Buxton J; Fernández B; Chawla A; Banerjee U; Czech MP
    Mol Cell Biol; 1997 Apr; 17(4):2217-25. PubMed ID: 9121472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
    Thien CB; Langdon WY
    Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Cbl: a regulator of T cell receptor-mediated signalling.
    Thien CB; Langdon WY
    Immunol Cell Biol; 1998 Oct; 76(5):473-82. PubMed ID: 9797470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LET-23-mediated signal transduction during Caenorhabditis elegans development.
    Sternberg PW; Lesa G; Lee J; Katz WS; Yoon C; Clandinin TR; Huang LS; Chamberlin HM; Jongeward G
    Mol Reprod Dev; 1995 Dec; 42(4):523-8. PubMed ID: 8607985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cbl oncogene: a novel substrate of protein tyrosine kinases.
    Langdon WY
    Aust N Z J Med; 1995 Dec; 25(6):859-64. PubMed ID: 8770364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
    Thien CB; Langdon WY
    Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
    Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
    Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor.
    Kassenbrock CK; Hunter S; Garl P; Johnson GL; Anderson SM
    J Biol Chem; 2002 Jul; 277(28):24967-75. PubMed ID: 11994282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases.
    Broome MA; Galisteo ML; Schlessinger J; Courtneidge SA
    Oncogene; 1999 May; 18(18):2908-12. PubMed ID: 10362262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
    Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
    J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
    Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
    J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cbl: many adaptations to regulate protein tyrosine kinases.
    Thien CB; Langdon WY
    Nat Rev Mol Cell Biol; 2001 Apr; 2(4):294-307. PubMed ID: 11283727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.